Endometrial cancer is a tumor with relatively good prognosis. Its recurrence rate is related to the stage, general condition, whether there is lymph node metastasis, depth of infiltration and pathological type. For early stage I and II endometrial cancer, the recurrence rate is only 15%, and it usually recurs within 3 years, so it should be reviewed regularly. If the recurrence is confined to the vagina or pelvis, it is an isolated lesion, and the prognosis is better after recurrence treatment, and the five-year survival rate can reach 50%-70%. Therefore, this disease is a tumor with a better prognosis.